FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2971159771> ?p ?o ?g. }

• W2971159771 abstract "The economics of allogeneic hematopoietic cell transplantation (alloHCT) for older patients with acute myeloid leukemia (AML) affects clinical practice and public policy. To assess reimbursement, utilization, and overall survival (OS) up to 1 year post-alloHCT for Medicare beneficiaries aged 65 years or older with AML, a unique merged dataset of Medicare claims and national alloHCT registry data was analyzed.Patients diagnosed with AML undergoing alloHCT from 2010 to 2011 were included for a retrospective cohort analysis with generalized linear model adjustment. One-year post-alloHCT reimbursement included Medicare, secondary payer, and beneficiary copayments (no coinsurance) (inflation adjusted to 2017 dollars). Cost-to-charge ratios were applied to estimate department-specific inpatient costs. Cox proportional hazards regression models were utilized to identify risk factors of 1-year OS post-alloHCT.A total of 250 patients met inclusion criteria. Mean total reimbursement was $230 815 (95% confidence interval [CI] = $214 381 to $247 249) 1 year after alloHCT. Pharmacy was the most- costly inpatient service category. Adjusted mean total reimbursement was statistically higher for patients who received cord blood grafts (P = .01), myeloablative conditioning (P < .0001), and alloHCT in the Northeast and West (P = .03). Mortality increased with age (hazard ratio [HR] = 1.08, 95% CI = 1.0 to 1.17), poorer Karnofsky performance score (<90% vs ≥90%, HR = 1.60, 95% CI = 1.08 to 2.35), and receipt of myeloablative conditioning (HR = 1.88, 95% CI = 1.21 to 2.92).This merged dataset allowed adjustment for a richer set of patient- and HCT-related characteristics than claims data alone. The finding that nonmyeloablative conditioning was associated with lower reimbursement and improved OS 1 year post-alloHCT warrants further investigation." @default.
• W2971159771 created "2019-09-05" @default.
• W2971159771 creator A5000023597 @default.
• W2971159771 creator A5004596593 @default.
• W2971159771 creator A5021742756 @default.
• W2971159771 creator A5046048880 @default.
• W2971159771 creator A5058016110 @default.
• W2971159771 creator A5058862489 @default.
• W2971159771 creator A5058981870 @default.
• W2971159771 creator A5061455564 @default.
• W2971159771 creator A5072552148 @default.
• W2971159771 creator A5081856428 @default.
• W2971159771 creator A5084230861 @default.
• W2971159771 date "2019-08-28" @default.
• W2971159771 modified "2023-10-08" @default.
• W2971159771 title "Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia" @default.
• W2971159771 cites W1606682320 @default.
• W2971159771 cites W1970773245 @default.
• W2971159771 cites W2014440969 @default.
• W2971159771 cites W2015410846 @default.
• W2971159771 cites W2019154801 @default.
• W2971159771 cites W2022333024 @default.
• W2971159771 cites W2044612846 @default.
• W2971159771 cites W2065738117 @default.
• W2971159771 cites W2092449369 @default.
• W2971159771 cites W2117550229 @default.
• W2971159771 cites W2119148496 @default.
• W2971159771 cites W2125080520 @default.
• W2971159771 cites W2132619403 @default.
• W2971159771 cites W2133486030 @default.
• W2971159771 cites W2140300831 @default.
• W2971159771 cites W2169668771 @default.
• W2971159771 cites W2314469789 @default.
• W2971159771 cites W2341931364 @default.
• W2971159771 cites W2387849425 @default.
• W2971159771 cites W2474902225 @default.
• W2971159771 cites W2557120254 @default.
• W2971159771 cites W2590139907 @default.
• W2971159771 cites W2594698743 @default.
• W2971159771 cites W2626517382 @default.
• W2971159771 cites W2744694358 @default.
• W2971159771 cites W2770747505 @default.
• W2971159771 cites W2782330085 @default.
• W2971159771 cites W2801298859 @default.
• W2971159771 cites W2806250856 @default.
• W2971159771 cites W2922313778 @default.
• W2971159771 doi "https://doi.org/10.1093/jncics/pkz048" @default.
• W2971159771 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6845850" @default.
• W2971159771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31750417" @default.
• W2971159771 hasPublicationYear "2019" @default.
• W2971159771 type Work @default.
• W2971159771 sameAs 2971159771 @default.
• W2971159771 citedByCount "5" @default.
• W2971159771 countsByYear W29711597712020 @default.
• W2971159771 countsByYear W29711597712021 @default.
• W2971159771 countsByYear W29711597712022 @default.
• W2971159771 countsByYear W29711597712023 @default.
• W2971159771 crossrefType "journal-article" @default.
• W2971159771 hasAuthorship W2971159771A5000023597 @default.
• W2971159771 hasAuthorship W2971159771A5004596593 @default.
• W2971159771 hasAuthorship W2971159771A5021742756 @default.
• W2971159771 hasAuthorship W2971159771A5046048880 @default.
• W2971159771 hasAuthorship W2971159771A5058016110 @default.
• W2971159771 hasAuthorship W2971159771A5058862489 @default.
• W2971159771 hasAuthorship W2971159771A5058981870 @default.
• W2971159771 hasAuthorship W2971159771A5061455564 @default.
• W2971159771 hasAuthorship W2971159771A5072552148 @default.
• W2971159771 hasAuthorship W2971159771A5081856428 @default.
• W2971159771 hasAuthorship W2971159771A5084230861 @default.
• W2971159771 hasBestOaLocation W29711597711 @default.
• W2971159771 hasConcept C126322002 @default.
• W2971159771 hasConcept C160735492 @default.
• W2971159771 hasConcept C162324750 @default.
• W2971159771 hasConcept C167135981 @default.
• W2971159771 hasConcept C194828623 @default.
• W2971159771 hasConcept C207103383 @default.
• W2971159771 hasConcept C2779703844 @default.
• W2971159771 hasConcept C2911091166 @default.
• W2971159771 hasConcept C44249647 @default.
• W2971159771 hasConcept C50382708 @default.
• W2971159771 hasConcept C50522688 @default.
• W2971159771 hasConcept C71924100 @default.
• W2971159771 hasConcept C72563966 @default.
• W2971159771 hasConceptScore W2971159771C126322002 @default.
• W2971159771 hasConceptScore W2971159771C160735492 @default.
• W2971159771 hasConceptScore W2971159771C162324750 @default.
• W2971159771 hasConceptScore W2971159771C167135981 @default.
• W2971159771 hasConceptScore W2971159771C194828623 @default.
• W2971159771 hasConceptScore W2971159771C207103383 @default.
• W2971159771 hasConceptScore W2971159771C2779703844 @default.
• W2971159771 hasConceptScore W2971159771C2911091166 @default.
• W2971159771 hasConceptScore W2971159771C44249647 @default.
• W2971159771 hasConceptScore W2971159771C50382708 @default.
• W2971159771 hasConceptScore W2971159771C50522688 @default.
• W2971159771 hasConceptScore W2971159771C71924100 @default.
• W2971159771 hasConceptScore W2971159771C72563966 @default.
• W2971159771 hasFunder F4320332175 @default.
• W2971159771 hasFunder F4320337338 @default.
• W2971159771 hasFunder F4320337345 @default.
• W2971159771 hasFunder F4320337351 @default.

• next